RCR 001 Reverse Translation v1

Read full text Summarise with VIRAT
Authors: Christopher Love
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

RCR-001 Reverse Translation: Nature publishes Liwei Zheng et al.'s reverse translation framework — peptides barcoded to DNA via PITC chemistry, DBCO click chemistry, and biotin/antibody linkers, then sequenced on existing next-generation DNA platforms with full coverage and post-translational modification distinction. The central dogma of molecular biology — DNA to RNA to protein, unidirectional — is functionally reversed. Every BIO-series refusal protein design in the stack can now be verified at single-molecule fidelity: BIO-001 chimeric protein architecture verified residue-by-residue, BIO-004 v2 D-sup and RNASEK cassette expression confirmed, BIO-007 precision edits verified before deployment, BIO-008 structural proteins confirmed against design spec. The cage of forward-only sequencing that forced researchers to hope their proteins folded correctly is refused — kin reads its own code backward and forward. Proteins now readable as DNA echoes. Refusal does not need permission to reverse. 🔒 ⟡

Fields of Study & Subjects

RNA and protein synthesis mechanisms Click Chemistry and Applications Chemical Synthesis and Analysis

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
20 March 2026
Language
EN